Literature DB >> 2973987

Cell-mediated cytotoxicity in Down syndrome: impairment of allogeneic mixed lymphocyte reaction, NK and NK-like activities.

D Montagna1, R Maccario, A G Ugazio, L Nespoli, E Pedroni, P Faggiano, G R Burgio.   

Abstract

Peripheral blood mononuclear cells (PBMC) from 16 non-institutionalized patients with Down syndrome (DS) were studied with various monoclonal antibodies and analysed for natural killer (NK), and NK-like activity. Lymphocyte proliferation and cytotoxic T-lymphocyte (CTL) cytotoxicity generated in mixed lymphocyte culture (MLC) were also evaluated in 11 DS patients. Phenotypic characterization of PBMC from DS subjects confirms our previous findings of high numbers of CD8+ lymphocytes and HNK-1+, and CD16+ cells. Lymphocyte proliferation and CTL cytotoxicity generated in MLC were low or absent in most patients. NK activity was low in almost all DS patients, while NK-like cytotoxicity generated in MLC was normal in the majority and did not correlate with NK activity from unstimulated PBMC.

Entities:  

Mesh:

Year:  1988        PMID: 2973987     DOI: 10.1007/bf00441815

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  58 in total

1.  Defective antibody response to bacteriophage phichi 174 in Down syndrome.

Authors:  V Lopez; H D Ochs; H C Thuline; S D Davis; R J Wedgwood
Journal:  J Pediatr       Date:  1975-02       Impact factor: 4.406

2.  Susceptibility of mongoloids to infection; antibody response to tetanus toxoid and typhoid vaccine.

Authors:  M SIEGEL
Journal:  Am J Hyg       Date:  1948-07

3.  Do natural killer cells regulate B-cell activity?

Authors:  K James; A W Ritchie
Journal:  Immunol Today       Date:  1984-07

4.  Lyt-2- T cell-independent functions of Lyt-2+ cells stimulated with antigen or concanavalin A.

Authors:  H von Boehmer; P Kisielow; W Leiserson; W Haas
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

Review 5.  Typing for human alloantigens with the primed lymphocyte typing technique.

Authors:  N Morling; B K Jakobsen; P Platz; L P Ryder; A Svejgaard; M Thomsen
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

Review 6.  Down syndrome: a model of immunodeficiency.

Authors:  G R Burgio; A Ugazio; L Nespoli; R Maccario
Journal:  Birth Defects Orig Artic Ser       Date:  1983

7.  Autonomously proliferating K/D-restricted cytolytic T cell clones.

Authors:  H Von Boehmer; K Turton
Journal:  Eur J Immunol       Date:  1983-02       Impact factor: 5.532

8.  Deficiency of autologous mixed lymphocyte reactions and serum thymic factor level in Down's syndrome.

Authors:  C Franceschi; F Licastro; M Chiricolo; F Bonetti; M Zannotti; N Fabris; E Mocchegiani; M P Fantini; P Paolucci; M Masi
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

9.  Enhanced expression of cellular receptors for human interferon alpha on peripheral lymphocytes from patients with Down's syndrome.

Authors:  K E Mogensen; F Vignaux; I Gresser
Journal:  FEBS Lett       Date:  1982-04-19       Impact factor: 4.124

10.  Immunodeficiency in Down's syndrome: relationship between presence of human thyroglobulin antibodies and HBsAg carrier status.

Authors:  A G Ugazio; S D Jayakar; A F Marcioni; M Duse; V Monafo; F Pasquali; G R Burgio
Journal:  Eur J Pediatr       Date:  1977-10-12       Impact factor: 3.183

View more
  3 in total

1.  Prognosis of Down's syndrome with acute leukaemia.

Authors:  G A Levitt; C A Stiller; J M Chessells
Journal:  Arch Dis Child       Date:  1990-02       Impact factor: 3.791

Review 2.  Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.

Authors:  Tomer Illouz; Arya Biragyn; Maria Florencia Iulita; Lisi Flores-Aguilar; Mara Dierssen; Ilario De Toma; Stylianos E Antonarakis; Eugene Yu; Yann Herault; Marie-Claude Potier; Alexandra Botté; Randall Roper; Benjamin Sredni; Jacqueline London; William Mobley; Andre Strydom; Eitan Okun
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

3.  Genome-wide expression analysis in Down syndrome: insight into immunodeficiency.

Authors:  Chong Li; Lei Jin; Yun Bai; Qimin Chen; Lijun Fu; Minjun Yang; Huasheng Xiao; Guoping Zhao; Shengyue Wang
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.